HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
15.08
-0.32 (-2.08%)
At close: Oct 17, 2025, 4:00 PM EDT
15.14
+0.06 (0.40%)
After-hours: Oct 17, 2025, 4:10 PM EDT
HUTCHMED (China) Market Cap
HUTCHMED (China) has a market cap or net worth of $2.53 billion as of October 17, 2025. Its market cap has decreased by -27.35% in one year.
Market Cap
2.53B
Enterprise Value
1.31B
1-Year Change
-27.35%
Ranking
Category
Stock Price
$15.08
Market Cap Chart
Since March 17, 2016, HUTCHMED (China)'s market cap has increased from $1.60B to $2.53B, an increase of 58.55%. That is a compound annual growth rate of 4.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2025 | 2.69B | 6.96% |
| Dec 31, 2024 | 2.51B | -19.95% |
| Dec 29, 2023 | 3.14B | 22.75% |
| Dec 30, 2022 | 2.56B | -50.05% |
| Dec 31, 2021 | 5.12B | 19.79% |
| Dec 31, 2020 | 4.27B | 27.79% |
| Dec 31, 2019 | 3.34B | 8.92% |
| Dec 31, 2018 | 3.07B | -35.89% |
| Dec 29, 2017 | 4.79B | 195.91% |
| Dec 30, 2016 | 1.62B | 1.27% |
| Mar 17, 2016 | 1.60B | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |